Exhibit 99.3 ALTERNATE VOTING AGREEMENT VOTING AGREEMENT, dated as of June 24, 1998, between Mylan Laboratories Inc., a Pennsylvania corporation ("Parent"), and Mark J. Gabrielson, individually and in his capacity as the general partner of Prince...Voting Agreement • June 30th, 1998 • Mylan Laboratories Inc • Pharmaceutical preparations • Delaware
RECITALS --------Stock Option Agreement • June 30th, 1998 • Mylan Laboratories Inc • Pharmaceutical preparations • Delaware
BY AND AMONGMerger Agreement • June 30th, 1998 • Mylan Laboratories Inc • Pharmaceutical preparations • Delaware
RECITALS:Executive Employment Agreement • June 26th, 2002 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
CONSULTING AGREEMENT THIS AGREEMENT, made and entered into as of July 27, 2000 by and between MYLAN LABORATORIES INC., a Pennsylvania corporation having an address at 1030 Century Building, 130 Seventh Street, Pittsburgh, PA 15222 ("Consultee"), and...Consulting Agreement • June 17th, 2002 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
Exhibit 99.2 VOTING AGREEMENT VOTING AGREEMENT, dated as of June 24, 1998, between Mylan Laboratories Inc., a Pennsylvania corporation ("Parent"), and the persons listed on Schedule A hereto (individually, a "Stockholder" and collectively, the...Voting Agreement • June 30th, 1998 • Mylan Laboratories Inc • Pharmaceutical preparations • Delaware
EXECUTION COPY MYLAN LABORATORIES INC. INDEMNIFICATION AGREEMENT This Indemnification Agreement (the "Agreement") is made this __ day of _________________, by and between Mylan Laboratories Inc., a Pennsylvania corporation (the "Corporation"), and...Indemnification Agreement • December 3rd, 2004 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
MYLAN LABORATORIES INC. (a Pennsylvania corporation) 22,750,000 Shares of Common Stock PURCHASE AGREEMENTPurchase Agreement • March 7th, 2007 • Mylan Laboratories Inc • Pharmaceutical preparations • New York
MERRILL LYNCH & CO. Merrill Lynch, Pierce, Fenner & Smith Incorporated as Representative of the several Underwriters to be named in the within mentioned Purchase Agreements 4 World Financial Center New York, New York 10080
CREDIT AGREEMENT dated as of June 27, 2013 among MYLAN INC., as the Borrower and BANK OF AMERICA, N.A., as Administrative Agent and the Lenders party heretoCredit Agreement • June 27th, 2013 • Mylan Inc. • Pharmaceutical preparations • New York
CREDIT AGREEMENT (this “Agreement”) dated as of June 27, 2013 among MYLAN INC., the LENDERS party hereto, and BANK OF AMERICA, N.A., as Administrative Agent.
REGISTRATION RIGHTS AGREEMENT Dated As of July 21, 2005 among Mylan Laboratories Inc. and The Guarantors Party Hereto and Merrill Lynch, Pierce, Fenner & Smith Incorporated, BNY Capital Markets, Inc., KeyBanc Capital Markets, a Division of McDonald...Registration Rights Agreement • July 27th, 2005 • Mylan Laboratories Inc • Pharmaceutical preparations • New York
This Registration Rights Agreement (the “Agreement”) is made and entered into this 21 day of July, 2005, among Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), each of the subsidiaries of the Company listed on the signature page hereto (the “Guarantors” and, together with the Company, the “Issuers”) and Merrill Lynch, Pierce, Fenner & Smith Incorporated, BNY Capital Markets, Inc., KeyBanc Capital Markets, a Division of McDonald Investments Inc., PNC Capital Markets, Inc. and Sun Trust Capital Markets, Inc. (collectively, the “Initial Purchasers”).
CREDIT AGREEMENT dated as of November 14, 2011 among MYLAN INC., as the Borrower and BANK OF AMERICA, N.A., as Administrative Agent MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED CITIGROUP GLOBAL MARKETS INC. CREDIT SUISSE SECURITIES (USA) LLC...Credit Agreement • November 15th, 2011 • Mylan Inc. • Pharmaceutical preparations • New York
CREDIT AGREEMENT (this “Agreement”) dated as of November 14, 2011 among MYLAN INC., the LENDERS party hereto, and BANK OF AMERICA, N.A., as Administrative Agent.
BY AND AMONGMerger Agreement • July 26th, 2004 • Mylan Laboratories Inc • Pharmaceutical preparations • New York
MYLAN INC., as Issuer, The Guarantors named herein, as Guarantors, and THE BANK OF NEW YORK MELLON, as Trustee INDENTURE Dated as of September 15, 2008 3.75% Cash Convertible Notes Due 2015Indenture • September 15th, 2008 • Mylan Inc. • Pharmaceutical preparations • New York
THIS INDENTURE, dated as of September 15, 2008, is among Mylan Inc., a corporation duly organized under the laws of the State of Pennsylvania (the “Company”), the Guarantors (as defined herein) and The Bank of New York Mellon, a New York banking corporation, as Trustee (the “Trustee”).
CREDIT AGREEMENT among MYLAN LABORATORIES INC., as Borrower, The Several Lenders from Time to Time Parties Hereto, MERRILL LYNCH & CO., MERRILL LYNCH, PIERCE, FENNER AND SMITH INCORPORATED, as Sole Lead Arranger, Sole Bookrunner and Syndication Agent,...Credit Agreement • July 27th, 2005 • Mylan Laboratories Inc • Pharmaceutical preparations • New York
CREDIT AGREEMENT, dated as of July 21, 2005, among MYLAN LABORATORIES INC., a Pennsylvania corporation (the “Borrower”), the several banks and other financial institutions or entities from time to time parties to this Agreement (the “Lenders”), MERRILL LYNCH & CO., MERRILL LYNCH, PIERCE, FENNER AND SMITH INCORPORATED, as sole lead arranger, sole bookrunner and syndication agent (in such capacity, the “Arranger”), KEYBANK NATIONAL ASSOCIATION, PNC BANK, NATIONAL ASSOCIATION, SUNTRUST BANK AND THE BANK OF NEW YORK, as co-documentation agents (in such capacity, the “Co-Documentation Agent”) and MERRILL LYNCH CAPITAL CORPORATION, as administrative agent (in such capacity, the “Administrative Agent”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • April 27th, 2012 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
This Transition and Succession Agreement (this “Agreement”) is dated as of January 10, 2006, by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and Harry A. Korman (“Executive”).
RECITALS:Executive Employment Agreement • August 6th, 2002 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
RETIREMENT BENEFIT AGREEMENT This Retirement Benefit Agreement (the "Agreement") is entered into on this 14th day of March, 1995 (the "Effective Date") by and between: Mylan Laboratories Inc., a Pennsylvania Corporation, with offices located at 781...Retirement Benefit Agreement • June 26th, 2001 • Mylan Laboratories Inc • Pharmaceutical preparations • West Virginia
ContractExecutive Employment Agreement • February 28th, 2014 • Mylan Inc. • Pharmaceutical preparations • New York
This Second Amended and Restated Executive Employment Agreement (the “Agreement”) is entered into on February 25, 2014, to be effective as of January 1, 2014 (the “Effective Date”) by and between Mylan Inc. (the “Company” or “Mylan”) and Rajiv Malik (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • April 30th, 2010 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
This Executive Employment Agreement (the “Agreement”) is dated as of February 24, 2010, by and between Mylan Inc. (the “Company” or “Mylan”) and John Sheehan (“Executive”).
TERM CREDIT AGREEMENT dated as of December 19, 2014 among MYLAN INC., as a Borrower and The other Borrowers and Guarantors party hereto and BANK OF AMERICA, N.A., as Administrative Agent and the Lenders party heretoTerm Credit Agreement • March 2nd, 2015 • Mylan Inc. • Pharmaceutical preparations • New York
This TERM CREDIT AGREEMENT (this “Agreement”) is dated as of December 19, 2014 among MYLAN INC., a Pennsylvania corporation (“Mylan”), certain Affiliates and Subsidiaries of Mylan from time to time party hereto as a Designated Borrower, Successor Borrower or Guarantor, each Lender from time to time party hereto, and BANK OF AMERICA, N.A., as Administrative Agent.
RETIREMENT BENEFIT AGREEMENTRetirement Benefit Agreement • February 9th, 2005 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
This Retirement Benefit Agreement (the “Agreement”) is entered into as of the 31st day of December, 2004 (the “Effective Date”) by and between:
CREDIT AGREEMENT dated as of July 24, 2006 among MYLAN LABORATORIES INC. The Lenders Party Hereto BANK OF TOKYO-MITSUBISHI UFJ TRUST COMPANY, CITIBANK, N.A. and PNC BANK, NATIONAL ASSOCIATION as Co-Documentation Agents MERRILL LYNCH CAPITAL...Credit Agreement • July 26th, 2006 • Mylan Laboratories Inc • Pharmaceutical preparations • New York
CREDIT AGREEMENT dated as of July 24, 2006 among MYLAN LABORATORIES INC., the LENDERS party hereto, Bank of Tokyo-Mitsubishi UFJ Trust Company, Citibank, N.A. and PNC Bank, National Association, as Co-Documentation Agents, MERRILL LYNCH CAPITAL CORPORATION, as Syndication Agent and JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, as Administrative Agent.
MYLAN INC., as Issuer, MYLAN N.V. as Guarantor and THE BANK OF NEW YORK MELLON, as Trustee FIRST SUPPLEMENTAL INDENTURE DATED as of FEBRUARY 27, 2015 TO THE INDENTURE DATED as of JUNE 25, 2013First Supplemental Indenture • February 27th, 2015 • Mylan Inc. • Pharmaceutical preparations • New York
First Supplemental Indenture (this “Supplemental Indenture”), dated as of February 27, 2015, among Mylan N.V., a public limited liability company (naamloze vennootschap) organized and existing under the laws of the Netherlands (the “Guarantor”), Mylan Inc., a Pennsylvania corporation (the “Company”), and The Bank of New York Mellon, as trustee under the Indenture referred to below (the “Trustee”).
REVOLVING CREDIT AGREEMENT dated as of December 19, 2014 among MYLAN INC., as a Borrower and The other Borrowers and Guarantors party hereto and BANK OF AMERICA, N.A., as Administrative Agent and the Lenders and the Issuing Banks party heretoRevolving Credit Agreement • March 2nd, 2015 • Mylan Inc. • Pharmaceutical preparations • New York
This REVOLVING CREDIT AGREEMENT (this “Agreement”) is dated as of December 19, 2014 among MYLAN INC., a Pennsylvania corporation (“Mylan”), certain Affiliates and Subsidiaries of Mylan from time to time party hereto as a Designated Borrower, Successor Borrower or Guarantor, each Lender and Issuing Bank from time to time party hereto, and BANK OF AMERICA, N.A., as Administrative Agent.
MYLAN INC., as Issuer, MYLAN N.V. as Guarantor and THE BANK OF NEW YORK MELLON, as Trustee SECOND SUPPLEMENTAL INDENTURE DATED as of FEBRUARY 27, 2015 TO THE INDENTURE DATED as of NOVEMBER 29, 2013Second Supplemental Indenture • February 27th, 2015 • Mylan Inc. • Pharmaceutical preparations • New York
Second Supplemental Indenture (this “Supplemental Indenture”), dated as of February 27, 2015, among Mylan N.V., a public limited liability company (naamloze vennootschap) organized and existing under the laws of the Netherlands (the “Guarantor”), Mylan Inc., a Pennsylvania corporation (the “Company”), and The Bank of New York Mellon, as trustee under the Indenture referred to below (the “Trustee”).
ContractSale and Purchase Agreement • February 27th, 2014 • Mylan Inc. • Pharmaceutical preparations
Portions of this exhibit have been omitted and filed separately with the Securities and Exchange Commission pursuant to a confidential treatment request. Omissions are designated as ***.
RECITALS:Executive Employment Agreement • December 3rd, 2004 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
CREDIT AGREEMENT dated as of October 2, 2007 among MYLAN LABORATORIES INC. MYLAN LUXEMBOURG 5 S.A R.L. The Lenders Party Hereto LASALLE BANK, NATIONAL ASSOCIATION and THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., NEW YORK BRANCH, as Co- Documentation Agents...Credit Agreement • November 1st, 2007 • Mylan Inc. • Pharmaceutical preparations • New York
CREDIT AGREEMENT (this “Agreement”) dated as of October 2, 2007 among MYLAN LABORATORIES INC., MYLAN LUXEMBOURG 5 S.A R.L., the LENDERS party hereto, LASALLE BANK NATIONAL ASSOCIATION and THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., NEW YORK BRANCH, as Co-Documentation Agents, MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED and CITIBANK, N.A., as Co-Syndication Agents, and JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, as Administrative Agent.
MYLAN INC. (a Pennsylvania corporation) 3.75% Cash Convertible Notes due 2015 PURCHASE AGREEMENTPurchase Agreement • September 15th, 2008 • Mylan Inc. • Pharmaceutical preparations • New York
GOLDMAN, SACHS & CO. as Representatives of the several Initial Purchasers to be named in the within mentioned Purchase Agreement 4 World Financial Center New York, New York 10080
MYLAN INC. (a Pennsylvania corporation) 1,860,000 Shares of 6.50% Mandatory Convertible Preferred Stock PURCHASE AGREEMENTPurchase Agreement • November 20th, 2007 • Mylan Inc. • Pharmaceutical preparations • New York
MERRILL LYNCH & CO. Merrill Lynch, Pierce, Fenner & Smith Incorporated GOLDMAN, SACHS & CO. as Representatives of the several Underwriters c/o Merrill Lynch & Co. Merrill Lynch, Pierce, Fenner & Smith Incorporated 4 World Financial Center New York, New York 10080
FORM OF SHAREHOLDER AGREEMENTShareholder Agreement • November 5th, 2014 • Mylan Inc. • Pharmaceutical preparations • New York
This Shareholder Agreement (this “Agreement”) is dated and effective as of __________ between and among Mylan N.V., a public limited liability corporation (naamloze vennootschap) organized under the Laws of the Netherlands (“New Mylan”), Abbott Laboratories, an Illinois corporation (“Abbott”), Laboratoires Fournier S.A.S., a simplified corporation (Société par actions simplifiée) organized under the Laws of France (“Abbott France”), Abbott Established Products Holdings Gibraltar Limited, a private company limited by shares organized under the Laws of Gibraltar (“Abbott Gibraltar”), and Abbott Investments Luxembourg S.à r.l., a Luxembourg private limited company (Société à responsabilité limitée) organized under the Laws of Luxembourg (“Abbott Luxembourg,” and together with Abbott, Abbott France and Abbott Gibraltar and each of their respective Permitted Transferees (as defined below), the “Abbott Shareholders”)1. New Mylan and the Abbott Shareholders are referred to in this Agreement i
AMENDMENT NO. 2 TO TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • May 16th, 2006 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
THIS AMENDMENT NO. 2 TO TRANSITION AND SUCCESSION AGREEMENT (this “Amendment”) by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and John P. O’Donnell (the “Executive”), is made as of April 3, 2006.
ContractExecutive Employment Agreement • February 28th, 2014 • Mylan Inc. • Pharmaceutical preparations • New York
This Third Amended and Restated Executive Employment Agreement (the “Agreement”) is entered into on February 25, 2014, to be effective as of January 1, 2014 (the “Effective Date”), by and between Mylan Inc. (the “Company”) and Robert J. Coury (the “Executive”).
ContractConfirmation of Otc Convertible Note Hedge • February 23rd, 2009 • Mylan Inc. • Pharmaceutical preparations
THIS CONFIRMATION AMENDS, REPLACES, SUPERSEDES AND RESTATES IN ITS ENTIRETY ALL PREVIOUS CONFIRMATIONS PERTAINING TO THIS TRANSACTION.
RETIREMENT BENEFIT AGREEMENTRetirement Benefit Agreement • February 24th, 2011 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
This Amended Retirement Benefit Agreement (the “Agreement”) is entered into as of the 22nd day of February, 2011 (the “Effective Date”) by and between:
